Influence of surfactants on the release behaviour and structural properties of sol-gel derived silica xerogels embedded with metronidazole

被引:5
作者
Czarnobaj, Katarzyna [1 ]
Sawicki, Wieslaw [1 ]
机构
[1] Med Acad Gdansk, Dept Phys Chem, PL-80416 Gdansk, Poland
关键词
Drug delivery/release; in vitro study; metronidazole; sol-gel method; IN-VITRO RELEASE; DRUG-DELIVERY; CARRIER; ANTIBIOTICS; KINETICS; SYSTEMS;
D O I
10.3109/10837450.2011.635151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to obtain stable and controlled release silica xerogels containing metronidazole (MT) prepared with surfactants with different charges: cetyltrimethylammonium bromide (CTAB), sodium dodecyl sulphate (SDS) and hydroxypropyl cellulose (HPC), which could be the promising carrier materials used as the implantable drug delivery systems. The xerogels were prepared by the sol-gel method. The influence of various formulation precursors on porosity parameters and drug release were investigated. Addition of surfactants showed a promising result in controlling the MT release. Dissolution study revealed increased release of MT from silica modified SDS and CTAB, whereas the release of MT from silica modified HPC considerably decreased, in comparison with unmodified silica. The addition of surfactants showed slight changes in porosity parameters. All xerogels are characterized by a highly developed surface area (701-642 m(2) g(-1)) and mesoporous structure. The correlation between pore size obtained matrices and release rate of drug was also observed. Based on the presented results of this study, it may be stated that applied xerogel matrices: pure silica and surfactants-modified silica could be promising candidates for the formulation in local delivery systems.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 33 条
[1]   Silica xerogel carrier material for controlled release of toremifene citrate [J].
Ahola, M ;
Kortesuo, P ;
Kangasniemi, I ;
Kiesvaara, J ;
Yli-Urpo, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :219-227
[2]  
Aughenbaugh W, 2001, J BIOMED MATER RES, V57, P321, DOI 10.1002/1097-4636(20011205)57:3<321::AID-JBM1174>3.0.CO
[3]  
2-S
[4]  
Avnir D, 2006, J MATER CHEM, V16, P1013, DOI 10.1039/5512706h
[5]   Sol-gel carrier systems for controlled drug delivery [J].
Böttcher, H ;
Slowik, P ;
Süss, W .
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 1998, 13 (1-3) :277-281
[6]   THE SOL-GEL PREPARATION OF SILICA-GELS [J].
BUCKLEY, AM ;
GREENBLATT, M .
JOURNAL OF CHEMICAL EDUCATION, 1994, 71 (07) :599-602
[7]  
CHEN KC, 1986, J NON-CRYST SOLIDS, V81, P227, DOI 10.1016/0022-3093(86)90272-3
[8]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[9]   Morphology and pore structure of silica xerogels made at low pH [J].
Curran, MD ;
Stiegman, AE .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 1999, 249 (01) :62-68
[10]   Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine [J].
Czarnobaj, Katarzyna ;
Czarnobaj, Joanna .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2008, 87B (01) :114-120